Cell Tumors | Norton Healthcare

Indication: Cell Tumors

Examining patterns of use for the NanoKnife® Irreversible Electroporation Device in the real world: the NanoKnife Product Registry (OM1)

NanoKnife treatment cancer patients

Registry

Principal Investigator: Robert Martin, M.D., PhD
University of Louisville Physicians - Surgical Oncology

Sponsor: AngioDynamics, Inc.

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.